COMMUNIQUÉS West-GlobeNewswire

Voting Rights and Shares Capital of the Company
20/10/2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
20/10/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 20 oct. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
AVITA Medical to Announce Third Quarter 2026 Financial Results
20/10/2026
VALENCIA, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, [...]
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
20/10/2026
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
20/10/2026
ALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on Tuesday, November 3, [...]
Intuitive Announces Third Quarter Earnings
20/10/2026
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]
LifeMD to Report Third Quarter 2026 Financial Results on November 9
20/10/2026
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care and pharmacy services, announces that it will report financial results for the three and nine months [...]
Teknova Announces Proposed Public Offering of Common Stock
20/10/2026
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Acquisition of Own Shares
20/10/2026
Mechelen, Belgium; October 20, 2026, 22.01 CEST; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Teknova Announces Preliminary Third Quarter Financial Results
20/10/2026
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
20/10/2026
WILMINGTON, Del., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
20/10/2026
Clinical conduct of both blarcamesine (ANAVEX®2-73) studies in healthy volunteers is now complete, data are expected to support clinical pharmacology characterization across pipeline programs NEW YORK, Oct. 20, 2026 ( [...]
Fortrea finalise l’acquisition de la division Early Phase Services de Worldwide Clinical Trials
20/10/2026
Élargit le réseau de développement clinique précoce de Fortrea grâce à des capacités bioanalytiques dédiées, un renforcement des unités de recherche clinique et une plateforme plus intégrée pour les clients Points forts [...]
Inside information: Orion upgrades full-year outlook for 2026
20/10/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 20 OCTOBER 2026 at 20.20 EEST Inside information: Orion upgrades full-year outlook for 2026 Orion Corporation upgrades the full-year outlook for 2026 both [...]
Le KFSH inaugure une unité de cathétérisme cardiaque directement au sein des urgences afin d’accélérer la prise en charge des cas critiques
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a mis en place un laboratoire de cathétérisme cardiaque au sein du service des urgences de son [...]
Le KFSH réduit de 75 % le temps d’attente aux urgences grâce à un système de gestion du flux de patients basés sur l’IA
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 75 % la durée d’attente médiane aux urgences de son établissement de Riyad, passant de [...]
La télésurveillance cardiaque au KFSH réduit de 46 % les hospitalisations liées à l’insuffisance cardiaque
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 46,4 % les hospitalisations pour insuffisance cardiaque décompensée chez les patients [...]
EssilorLuxottica: Q3 2026 Revenue - Revenue growth at 9.0% in Q3, +7.2% at constant currency
20/10/2026
Revenue growth at 9.0% in Q3, +7.2% at constant currency Group revenue +9.0% to Euro 7,486 million in Q3, +7.2% at constant ER 1 on top of double-digit growth of last year Group revenue +6.8% to Euro 22,304 million in [...]
EssilorLuxottica: Chiffre d'affaires T3 - Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants
20/10/2026
Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants Chiffre d’affaires du Groupe en hausse de +9,0 %, à 7 486 millions d’euros au T3, +7,2 % à taux de change constants¹, après une [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum